Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose, Vaccination site erythema, Vaccination site pain, Vaccination site rash
Clinical narrative: Injection site had leakage after fluid injection in right arm about two drops of vaccine; Injection site had leakage after fluid injection in right arm about two drops of vaccine; a localized red rash was observed at the site; a localized red rash was observed at the site; a localized red rash was observed at the site for several days following the injection accompanied with mild soreness; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (Injection site had leakage after fluid injection in right arm about two drops of vaccine), DEVICE CONNECTION ISSUE (Injection site had leakage after fluid injection in right arm about two drops of vaccine), VACCINATION SITE ERYTHEMA (a localized red rash was observed at the site), VACCINATION SITE RASH (a localized red rash was observed at the site) and VACCINATION SITE PAIN (a localized red rash was observed at the site for several days following the injection accompanied with mild soreness) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included Acute bronchitis from 20-Jan-2021 to 01-Mar-2021 and Hashimoto's disease on 01-Aug-1998. Concomitant products included LEVOTHYROXINE and LIOTHYRONINE for Hypothyroidism.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced UNDERDOSE (Injection site had leakage after fluid injection in right arm about two drops of vaccine), DEVICE CONNECTION ISSUE (Injection site had leakage after fluid injection in right arm about two drops of vaccine), VACCINATION SITE ERYTHEMA (a localized red rash was observed at the site), VACCINATION SITE RASH (a localized red rash was observed at the site) and VACCINATION SITE PAIN (a localized red rash was observed at the site for several days following the injection accompanied with mild soreness). On 17-Mar-2021, UNDERDOSE (Injection site had leakage after fluid injection in right arm about two drops of vaccine) had resolved. At the time of the report, DEVICE CONNECTION ISSUE (Injection site had leakage after fluid injection in right arm about two drops of vaccine), VACCINATION SITE ERYTHEMA (a localized red rash was observed at the site), VACCINATION SITE RASH (a localized red rash was observed at the site) and VACCINATION SITE PAIN (a localized red rash was observed at the site for several days following the injection accompanied with mild soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient taken oral NSAIDS for her events. No relevant concomitant medication was reported. .   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Patient demographics, vaccine facility information ,medical history, concomitant medication and new events were added.